SCHEMBL75670

SCHEMBL75670

NC(CC1CC1)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL75669 1.00
SCHEMBL2380451 1.00
Hydrochloric Acid SCHEMBL21058970 0.98 ANPEP (0.46)
Hydrochloric Acid SCHEMBL21058967 0.98 ANPEP (0.46)
SCHEMBL24520174 0.91 CPB2 (0.45)
SCHEMBL11218011 0.91 ANPEP (0.42)
SCHEMBL5103970 0.91 CPB2 (0.45)
SCHEMBL24520198 0.91 PLG (0.52)
SCHEMBL9182828 0.91 CPB2 (0.45)
SCHEMBL1578235 0.91 ANPEP (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 994 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240197896-A1 SYNTHETIC PEPTIDE SHUTTLE AGENT BIOCONJUGATES FOR INTRACELLULAR CARGO DELIVERY FELDAN BIO INC. (CA) 2024-06-20 US claimed
CN-117750978-A Synthetic peptide shuttle bioconjugates for intracellular cargo delivery 费尔丹生物公司 2024-03-22 CN claimed
EP-4313159-A1 SYNTHETIC PEPTIDE SHUTTLE AGENT BIOCONJUGATES FOR INTRACELLULAR CARGO DELIVERY Feldan Bio Inc. (CA) 2024-02-07 EP claimed
US-20230399661-A1 SHUTTLE AGENT PEPTIDES OF MINIMAL LENGTH AND VARIANTS THEREOF ADAPTED FOR TRANSDUCTION OF CAS9-RNP AND OTHER NUCLEOPROTEIN CARGOS FELDAN BIO INC. (CA) 2023-12-14 US claimed
EP-4232590-A1 SHUTTLE AGENT PEPTIDES OF MINIMAL LENGTH AND VARIANTS THEREOF ADAPTED FOR TRANSDUCTION OF CAS9-RNP AND OTHER NUCLEOPROTEIN CARGOS Feldan Bio Inc. (CA) 2023-08-30 EP claimed
CN-116615227-A Minimum length shuttle peptide suitable for transduction of Cas9-RNP and other nucleoprotein loads and variants thereof 费尔丹生物公司 2023-08-18 CN claimed
CN-116615205-A Peptide-based transduction of non-anionic polynucleotide analogs for modulation of gene expression 费尔丹生物公司 2023-08-18 CN claimed
WO-2023044509-A1 PROCESS FOR MAKING CYSTEINE PROTEASE INHIBITORS AND COMPOUNDS PROVIDED BY THAT PROCESS Pardes Biosciences, Inc. (US) 2023-03-23 WO claimed
US-20220204561-A1 PEPTIDE-BASED NON-PROTEINACEOUS CARGO DELIVERY FELDAN BIO INC. (CA) 2022-06-30 US claimed
WO-2022082315-A1 SHUTTLE AGENT PEPTIDES OF MINIMAL LENGH AND VARIANTS THEREOF ADAPTED FOR TRANSDUCTION OF CAS9-RNP AND OTHER NUCLEOPROTEIN CARGOS FELDAN BIO INC. (CA) 2022-04-28 WO claimed
CN-1973037-B Process for producing dipeptide or dipeptide derivative KYOWA HAKKO KOGYO KK 2011-10-19 CN claimed
WO-2010096142-A1 OXYNTOMODULIN ANALOGS MERCK SHARP & DOHME, CORP. (US) 2010-08-26 WO claimed
WO-2010096052-A1 OXYNTOMODULIN ANALOGS MERCK SHARP & DOHME CORP. (US) 2010-08-26 WO claimed
EP-1237846-B1 PREPARATION OF 3-AMINO-3-CYCLOPROPYLPROPANOATE ESTERS EASTMAN CHEM CO (US) 2004-05-19 EP claimed
US-20040072743-A1 Pharmaceutical composition of modified pna molecules PANTHECO A/S (DK) 2004-04-15 US claimed
EP-1296718-A1 PHARMACEUTICAL COMPOSITION OF MODIFIED PNA MOLECULES Pantheco A/S (DK) 2003-04-02 EP claimed
EP-1237846-A1 PREPARATION OF 3-AMINO-3-CYCLOPROPYLPROPANOATE ESTERS EASTMAN CHEMICAL COMPANY (US) 2002-09-11 EP claimed
WO-2001076636-A2 PHARMACEUTICAL COMPOSITION OF MODIFIED PNA MOLECULES PANTHECO A/S (DK) 2001-10-18 WO claimed
WO-2001044168-A1 PREPARATION OF 3-AMINO-3-CYCLOPROPYLPROPANOATE ESTERS EASTMAN CHEMICAL COMPANY (US) 2001-06-21 WO claimed
EP-0989136-A1 PEPTIDES HAVING CYCLIC STRUCTURES AND EXERTING P53 PROTEIN ACTIVTY-RESTORING EFFECT ON P53 PROTEIN MUTANTS KYOWA HAKKO KOGYO CO., LTD. (JP) 2000-03-29 EP claimed